• Antitrust/Competition
  • Clear
  • Most Recent
  • Most Relevant
361 results
Alert
Four key antitrust events in Q4 2021 target labor markets and aim to protect workers: Here's what you need to know
LIghthouse
Insight
Shining a light on the massive global surge in merger control filings
The data White & Case gathered from 58 of the most active merger control jurisdictions globally reveals trends and insights that can't be gleaned from data on single jurisdictions considered in isolation.
Alert
JFTC and METI Proposes Guidelines for Business Collaboration with Startups and Investment in Startups
Alert
German and Austrian competition authorities publish updated joint guidance on transaction value thresholds
Alert
New Capitalism in the Kishida Administration and Competition Policy in Japan
Alert
Key Developments in Saudi Arabia Merger Control: First Rejection, Review Guidelines, and New Tools
Article
Lexology GTDT: EU Antitrust Developments in the Pharmaceutical Sector
Article
Law360 Expert Analysis: Questions To Ask If Doing Business In A Corruption Hot Spot
Alert
Everybody Needs Prior Approval! – The FTC Revives And Expands an Old Enforcement Tool over a Scathing Dissent
Alert
No-poach agreements on the European Commission dawn raid radar
Alert
The Italian Government Approves the Draft Annual Law for Competition (ddl Concorrenza)
Article
United States: Pharmaceutical Antitrust 2022
Alert
UK clampdown on greenwashing
Taiwanese investors and businesses: Forging a path through global transitions
Insight
Taiwanese investors and businesses: Forging a path through global transitions
Key legal developments in 2021 and their implications for Taiwan
desktop source code
Insight
US antitrust policy targets the technology sector
Taiwanese companies could feel the impact of the current push for wide-scale change
circuit board
Insight
Europe takes a tougher approach to technology mergers
Taiwanese companies should keep Europe in mind when planning new deals
Alert
HHS Report Reiterates Biden Administration Support for Wide-Ranging Action to Address Drug Prices
Alert
Autumn dawn raid revival on the cards for European competition authorities
race track
Video
The Supreme Court's NCAA Decision and Its Implications for Antitrust Law
Alert
States Remain the Drivers of New Drug Pricing Legislation As Washington Weighs In
Article
Third Circuit: Pharmaceutical Cases
Alert
Federal Trade Commission’s Pre-Consummation Warning Letters Signal New Risk of Closing After Hart-Scott-Rodino Act Waiting Period Expiration
Alert
Technology Industry Should Watch Closely as the Executive Branch and Lawmakers Set Their Sights on Antitrust
Alert
UK National Security and Investment Act screening regime to go live from 4 January 2022
Alert
Analysis: FTC Encouraged to Ban or Limit Non-Compete Agreements in July 9, 2021 Executive Order; Breaks With Tradition, And Follows Trend of Heightened Antitrust Focus on Labor Markets
Alert
New EU competition rules for distribution agreements
Alert
What Does President Biden’s July 9, 2021 Executive Order on Competition Mean for the Pharma Industry?
World in transition
Insight
Sweeping US Order on “Promoting Competition”
The new Executive Order includes 72 initiatives instructing more than a dozen federal agencies to consider adopting rules intended to enhance competition. 
Alert
House Bill Mandating User Data Portability and Platform Interoperability Could Impact Digital Companies of All Sizes
Alert
The Rise of Global Mediation: A New Treaty Portends Growth
Article
The Legal 500 Merger Control (5th Edition)
Alert
European Commission consumer IoT sector inquiry: Preliminary Report
Alert
New York’s Sweeping New Antitrust Bill—Requiring NY State Premerger Notification ($9.2M Filing Threshold) and Prohibiting “Abuse of Dominance”—Inches Closer to Becoming Law
Alert
Electric vehicle charging market study: CMA to include package of remedies in its Summer 2021 market study report
World in transition
Insight
What’s next for drug pricing in the US?
New challenges may lie ahead for the pharmaceutical industry
Alert
DOJ Antitrust Division quietly walks back prior administration-era support of Standard Essential Patent holders
Alert
Federal Lawmakers Turn Their Sights to Drug Pricing, Introducing a Package of Bills Seeking Changes to Antitrust and Patent Law
stormy seas
Insight
Global merger control: Navigating stormy seas
There have been a number of developments in merger control in 2020 and Q1 2021. Some are related to the repercussions of the COVID-19 pandemic, while others are borne out of the ambitions and changes sought by individual competition authorities or unexpected jurisprudence
stormy seas
Insight
Global merger control: Introduction
European Parliament
Insight
European Union
The COVID-19 pandemic, and the ensuing lockdown measures—along with some landmark judgments— have led the European Commission's Directorate General for Competition to reflect on its approach to merger control notifications and reviews